Medtronic to buy Kyphon for $3.9 billion

07/27/2007 | Bloomberg

Medtronic will purchase spinal device specialist Kyphon for $3.9 billion as part of the company's strategy to diversify into new sectors of the market. The deal, which includes an agreement for Medtronic to drop a patent-infringement lawsuit against Kyphon, will give Medtronic access to Kyphon's global sales representatives and products for treating older patients' spinal injuries.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC